14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NPCE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of NeuroPace, Inc. stock downgraded after the last trading session.
(Updated on Apr 25, 2024)

Sell candidate since Apr 25, 2024 PDF

The NeuroPace, Inc. stock price fell by -4.20% on the last day (Thursday, 25th Apr 2024) from $13.56 to $12.99. During the last trading day the stock fluctuated 4.09% from a day low at $12.96 to a day high of $13.49. The price has fallen in 6 of the last 10 days and is down by -10.44% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -12 thousand shares and in total, 32 thousand shares were bought and sold for approximately $416.04 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.02% during the next 3 months and, with a 90% probability hold a price between $9.91 and $13.15 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NPCE Signals & Forecast

There are few to no technical positive signals at the moment. The NeuroPace, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $13.76 and $13.69. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 08, 2024, and so far it has fallen -15.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for NeuroPace, Inc. stock

NeuroPace, Inc. finds support from accumulated volume at $12.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.530 between high and low, or 4.09%. For the last week the stock has had daily average volatility of 5.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NPCE) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect NeuroPace, Inc. to open at $13.15, and during the day (based on 14 day Average True Range), to move between $12.15 and $13.83, which gives a possible trading interval of +/-$0.84 (+/-6.46%) up or down from last closing price. If NeuroPace, Inc. takes out the full calculated possible swing range there will be an estimated 12.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.84 (1.15%) than the resistance at $13.50 (3.93%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NeuroPace, Inc. stock A Buy?

NeuroPace, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -4.060 Sell Candidate Downgraded

Predicted Opening Price for NeuroPace, Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$13.15 ( 1.21%) $12.99

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NPCE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.68 5.29 %
R2 13.47 3.73 %
R1 13.35 2.76 %
Current price: 12.99
Support S1 12.94 -0.353 %
S2 12.82 -1.32 %
S3 12.62 -2.87 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.51 11.66 %
R2 13.98 7.62 %
R1 13.50 3.93 %
Current price 12.99
Support S1 12.84 -1.15%
S2 12.79 -1.54%
S3 12.70 -2.23%

FAQ

What is the symbol for NeuroPace, Inc. Stock and on which exchange is it traded?
The symbol for NeuroPace, Inc. is NPCE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeuroPace, Inc. Stock?
NeuroPace, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy NeuroPace, Inc. Stock?
NeuroPace, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeuroPace, Inc. Stock.

What's the current price of NeuroPace, Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an NeuroPace, Inc. (NPCE) share was $12.99.

What is the 52-week high and low for NeuroPace, Inc. Stock?
The 52-week high for NeuroPace, Inc. Stock is $18.15 and the 52-week low is $3.81.

What is the market capitalization of NeuroPace, Inc. Stock?
As of the Apr 25, 2024, the market capitalization of NeuroPace, Inc. is 368.196M.

When is the next earnings date for NeuroPace, Inc.?
The upcoming earnings date for NeuroPace, Inc. is May 08, 2024.
Click to get the best stock tips daily for free!

About NeuroPace, Inc.

NeuroPace. NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie... NPCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT